Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q2 2023 Earnings Call Transcript July 25, 2023
Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.17.
Operator: Good day, and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation there will be a question and answer session. [Operator Instructions]...
